Lack of optimism for Alzheimer’s trials means there’s little to lose

Companies searching for a cure for Alzheimer’s disease have spent an incredible amount of money over the past few decades, with little to no result. Some upcoming trial results are treated like long shots in the investment and medical communities, meaning good news would have a seismic impact.

Since 1995, more than $42.5 billion has been spent recruiting thousands of patients into more than 1,000 trials. However, to date, no treatment is available to cure or slow the progression of the disease.


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button